HSDT vs. IONM, SDCCQ, GMVDF, VRAYQ, SONX, AFIB, NMRD, UTRS, MOTS, and VIVE
Should you be buying Helius Medical Technologies stock or one of its competitors? The main competitors of Helius Medical Technologies include Assure (IONM), SmileDirectClub (SDCCQ), G Medical Innovations (GMVDF), ViewRay (VRAYQ), Sonendo (SONX), Acutus Medical (AFIB), Nemaura Medical (NMRD), Minerva Surgical (UTRS), Motus GI (MOTS), and Viveve Medical (VIVE). These companies are all part of the "medical equipment" industry.
Helius Medical Technologies vs. Its Competitors
Helius Medical Technologies (NASDAQ:HSDT) and Assure (NASDAQ:IONM) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, valuation, institutional ownership, earnings, analyst recommendations, risk, media sentiment and profitability.
Helius Medical Technologies has a net margin of -7,215.25% compared to Assure's net margin of -25,178.32%. Assure's return on equity of 0.00% beat Helius Medical Technologies' return on equity.
In the previous week, Helius Medical Technologies had 1 more articles in the media than Assure. MarketBeat recorded 1 mentions for Helius Medical Technologies and 0 mentions for Assure. Helius Medical Technologies' average media sentiment score of 1.88 beat Assure's score of 0.00 indicating that Helius Medical Technologies is being referred to more favorably in the media.
18.6% of Helius Medical Technologies shares are owned by institutional investors. Comparatively, 3.3% of Assure shares are owned by institutional investors. 17.9% of Helius Medical Technologies shares are owned by insiders. Comparatively, 3.8% of Assure shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
Helius Medical Technologies has a beta of 0.73, suggesting that its share price is 27% less volatile than the S&P 500. Comparatively, Assure has a beta of 185.12, suggesting that its share price is 18,412% more volatile than the S&P 500.
Helius Medical Technologies has higher revenue and earnings than Assure.
Summary
Helius Medical Technologies beats Assure on 9 of the 12 factors compared between the two stocks.
Get Helius Medical Technologies News Delivered to You Automatically
Sign up to receive the latest news and ratings for HSDT and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding HSDT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Helius Medical Technologies Competitors List
Related Companies and Tools
This page (NASDAQ:HSDT) was last updated on 8/28/2025 by MarketBeat.com Staff
MarketBeat All Access